Cephalon, Inc. is an indirect wholly owned subsidiary of Teva Pharmaceutical Industries Ltd, is , is reviewed in terms of partnering, licensing and M&A interests and activity over recent years.
Headquarters: Pennsylvannia, USA
Ticker Symbol: CEPH (Nasdaq Stock Exchange) CP9 (Frankfurt Stock Exchange)
SEC Link: Cephalon
The remaining part of this article is Premium content – see below for access options.
CP Insight – Premium content section
This is a premium content section and requires a paid subscription to access.